Inside Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.13M

  • Investors
  • 5

Inside Therapeutics General Information

Description

Operator of a deep tech company intended to provide scientists with the right tools to help them test and scale up their production of liposomes, lipid nanoparticles, and polymer nano-drugs. The company specializes in lipid nanoparticle synthesis with microfluidics and is developing a microfluidic-based nanoparticle synthesis platform, enabling the healthcare industry to ensure seamless scalability all along the nanoparticle-based drug development process.

Contact Information

Website
www.insidetx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 rue Marc Sagnier
  • 33130 Bègles
  • France
+33 07
Primary Industry
Other Healthcare Technology Systems
Other Industries
Business/Productivity Software
Drug Discovery
Vertical(s)
Nanotechnology, LOHAS & Wellness, SaaS, HealthTech
Corporate Office
  • 2 rue Marc Sagnier
  • 33130 Bègles
  • France
+33 07

Inside Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inside Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 06-Jun-2025 $1.13M Completed Generating Revenue
2. Early Stage VC 20-Jun-2024 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
To view Inside Therapeutics’s complete valuation and funding history, request access »

Inside Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
P2 Shares
Ordinary
To view Inside Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Inside Therapeutics Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Inside Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026223929-A1 Microfluidic mixing device with optimised configuration Pending 22-Apr-2025
FR-3174328-A1 Optimized microfluid mixing device Pending 22-Apr-2025
FR-3162511-A1 Method for detecting the arrival of a liquid front in a valve Active 22-May-2024
FR-3162511-B1 Method for detecting the arrival of a liquid front in a valve Active 22-May-2024
WO-2025168487-A1 Method for draining reservoirs of a microfluidic mixer Pending 07-Feb-2024 B01F33/305
To view Inside Therapeutics’s complete patent history, request access »

Inside Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inside Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aquiti PE/Buyout Minority
Microfluidics Innovation Center Corporation Minority
Newfund Management Venture Capital Minority
SkalePark Family Office Minority
Iventure (Grenoble) Accelerator/Incubator
To view Inside Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Inside Therapeutics FAQs

  • When was Inside Therapeutics founded?

    Inside Therapeutics was founded in 2022.

  • Where is Inside Therapeutics headquartered?

    Inside Therapeutics is headquartered in Bègles, France.

  • What is the size of Inside Therapeutics?

    Inside Therapeutics has 20 total employees.

  • What industry is Inside Therapeutics in?

    Inside Therapeutics’s primary industry is Other Healthcare Technology Systems.

  • Is Inside Therapeutics a private or public company?

    Inside Therapeutics is a Private company.

  • What is the current valuation of Inside Therapeutics?

    The current valuation of Inside Therapeutics is .

  • What is Inside Therapeutics’s current revenue?

    The current revenue for Inside Therapeutics is .

  • How much funding has Inside Therapeutics raised over time?

    Inside Therapeutics has raised $2.54M.

  • Who are Inside Therapeutics’s investors?

    Aquiti, Microfluidics Innovation Center, Newfund Management, SkalePark, and Iventure (Grenoble) have invested in Inside Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process